Research |
![]() ![]() ![]() ![]() ![]() |
Serial Number | 79305125 |
Registration Number | 6726756 |
Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
2021-01-18 | Application Filed |
2021-02-25 | Location: INITIAL REVIEW/SERIALIZATION BRANCH(MAILROOM) |
2021-02-25 | Status: Live/Pending |
2021-03-01 | Transaction Date |
2022-05-24 | Trademark Registered |
Owner: | ![]() |
Address | 23, Academy-ro, Yeonsu-gu Incheon 22014 KR |
Legal Entity Type | Corporation |
Legal Entity State | KR |
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
International Codes: | 44 |
U.S. Codes: | 100,101 |
Type Code | Type |
---|---|
GS0441 | Healthcare; health counselling; medical and health care services; medical information services provided via the internet; information services relating to medical products; consultancy and information services relating to biopharmaceutical products; consultancy and information services relating to pharmaceutical products; consultancy and information services provided via the internet relating to pharmaceutical products; consultancy relating to pharmaceutical and medical products; medical consultancy for selecting appropriate medicines; providing information in the field of medicine; advisory services relating to pharmaceutical products; advisory services relating to health care; patient support services for disease diagnosis and treatment; patient support services related to autoimmune disease treatment |
GS0441 | Healthcare; health counselling; medical and health care services; medical information services provided via the internet; Information services relating to medical products, namely, providing information concerning the proper use of medical treatment apparatus and instruments for biopharmaceutical use; Providing consultancy and information services in the field of biopharmaceutical products; Providing consultancy and information services in the field of pharmaceutical products; Providing consultancy and information services provided via the internet in the field of pharmaceutical products; providing consultancy in the field of pharmaceuticals; providing consultancy in the field of medical products in the nature of diagnostic medical testing; medical consultancy for selecting appropriate medicines; providing information in the field of medicine; advisory services relating to pharmaceutical products; advisory services relating to health care; patient support services for disease diagnosis and treatment in the field of autoimmune disease; patient support services in the field of medical autoimmune disease treatment |
Description | Date | Event Coding |
---|---|---|
SN ASSIGNED FOR SECT 66A APPL FROM IB | 2021-02-25 | 1 REPR M: |
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2021-03-01 | 2 NWOS I:Incoming Correspondence |
APPLICATION FILING RECEIPT MAILED | 2021-03-05 | 3 MAFR O:Outgoing Correspondence |
ASSIGNED TO EXAMINER | 2021-03-16 | 4 DOCK D:Assigned to Examiner |
NON-FINAL ACTION WRITTEN | 2021-03-16 | 5 CNRT R:Renewal |
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | 2021-03-17 | 6 RFCR E:E-Mail |
REFUSAL PROCESSED BY MPU | 2021-03-17 | 7 RFRR P: |
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | 2021-03-18 | 8 RFCS P: |
REFUSAL PROCESSED BY IB | 2021-04-05 | 9 RFNT P: |
CHANGE OF OWNER RECEIVED FROM IB | 2021-06-12 | 10 CHLD M: |
NEW REPRESENTATIVE AT IB RECEIVED | 2021-07-09 | 11 NREP P: |
TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2021-09-16 | 12 TROA I:Incoming Correspondence |
CORRESPONDENCE RECEIVED IN LAW OFFICE | 2021-09-16 | 13 CRFA I:Incoming Correspondence |
TEAS/EMAIL CORRESPONDENCE ENTERED | 2021-09-16 | 14 TEME I:Incoming Correspondence |
TEAS CHANGE OF OWNER ADDRESS RECEIVED | 2021-09-16 | 15 COAR I:Incoming Correspondence |
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2021-09-16 | 16 REAP I:Incoming Correspondence |
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2021-09-16 | 17 ARAA I:Incoming Correspondence |
TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2021-09-16 | 18 TCCA I:Incoming Correspondence |
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | 2021-09-16 | 19 CHAN I:Incoming Correspondence |
EXAMINERS AMENDMENT -WRITTEN | 2021-10-28 | 20 CNEA R:Renewal |
EXAMINERS AMENDMENT E-MAILED | 2021-10-28 | 21 GNEA O:Outgoing Correspondence |
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | 2021-10-28 | 22 GNEN O:Outgoing Correspondence |
EXAMINER'S AMENDMENT ENTERED | 2021-10-28 | 23 XAEC I:Incoming Correspondence |
APPROVED FOR PUB - PRINCIPAL REGISTER | 2021-10-28 | 24 CNSA O:Outgoing Correspondence |
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2021-11-10 | 25 NONP E:E-Mail |
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | 2021-11-17 | 26 OP2R P: |
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | 2021-11-17 | 27 OPNS P: |
PUBLISHED FOR OPPOSITION | 2021-11-30 | 28 PUBO A:Allowance for Publication |
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2021-11-30 | 29 NPUB E:E-Mail |
NOTIFICATION PROCESSED BY IB | 2021-12-06 | 30 GPNX P: |
EXTENSION OF TIME TO OPPOSE RECEIVED | 2021-12-29 | 31 ETOF T:TTAB Proceeding |
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED | 2022-04-10 | 32 ETOP T:TTAB Proceeding |
REGISTERED-PRINCIPAL REGISTER | 2022-05-24 | 33 R.PR A:Allowance for Publication |
NOTICE OF REGISTRATION CONFIRMATION EMAILED | 2022-05-24 | 34 NRCC E:E-Mail |
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | 2022-08-24 | 35 FICR P: |
FINAL DISPOSITION PROCESSED | 2022-09-08 | 36 FIMP P: |
FINAL DISPOSITION NOTICE SENT TO IB | 2022-09-08 | 37 FICS P: |
FINAL DECISION TRANSACTION PROCESSED BY IB | 2022-10-02 | 38 FINO P: |
CHANGE OF NAME/ADDRESS REC'D FROM IB | 2022-12-02 | 39 ADCH M: |
CHANGE OF NAME/ADDRESS REC'D FROM IB | 2023-10-21 | 40 ADCH M: |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.